Navigation Links
JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer
Date:9/9/2009

Researchers confirmed previous findings that the sexual transmitted infection known as Trichomonas vaginalis is associated with an increased risk of prostate cancer in a study published online September 9 in the Journal of the National Cancer Institute.

Jennifer Rider Stark, ScD, of the department of epidemiology at the Harvard School of Public Health in Boston, and colleagues conducted a case-control study nested within the Physicians' Health Study that included 673 case subjects with prostate cancer and 673 individually matched control subjects. Plasma was assayed for antibodies against T. vaginalis. The relationship of incident prostate cancer, extraprostatic prostate cancer, and cancer predicted to progress to bony metastases or prostate cancerspecific death was investigated.

Although not statistically significant, the size of the association between T. vaginalisseropositive status and overall prostate cancer risk was similar to that reported previously. A seropositive status was associated with statistically significantly increased risks of extraprostatic prostate cancer and cancer that is likely to progress to bony metastases or prostate cancerspecific death.

"If our findings are confirmed, T. vaginalis could serve as a marker for adverse outcomes in patients for prostate cancer or, more optimistically as a target for secondary chemoprevention," the authors write.

In an accompanying editorial, Peter C. Albertsen, M.D., of the University of Connecticut Health Center, in Farmington, Conn., said that this study is another example of assessing a specific variable to determine the risk of prostate cancer that deserves serious attention.

"Unfortunately, an unintended consequence of prostate-antigen testing is the large number of men diagnosed with incidental disease that now confounds our ability to identify potential causes of clinically significant disease," writes the editorialist, who also pointed out that a much larger study would be required to detect a statistically significant difference between seropositivity and overall prostate cancer risk.


'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. JNCI news brief: Melanosome dynamics and sensitivity of melanoma cells to chemotherapy
2. JNCI news brief: Surgeon training found effective in breast cancer sentinel lymph node trial
3. JNCI news brief: High serum insulin levels and risk of prostate cancer
4. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
5. JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumor
6. JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer
7. JNCI news brief: Improving the biomarker pipeline for early cancer detection
8. In brief: New prognostic indicator for patients with IPF
9. Asymchem Announces Fall Process Symposium Confirmed List of Speakers
10. Medifast Independent Director Lt. Gen. Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs
11. Link between migraines and reduced breast cancer risk confirmed in follow-up study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... financial consultations to communities in northern Virginia and DC, is announcing a cooperative ... for patients with Alzheimer’s and other disorders that lead to memory impairment. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 percent of ... released today by the American Society for Dermatologic Surgery (ASDS). , ... of consumers considering a cosmetic medical procedure has doubled since 2013. , “Cosmetic ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... for many of the health care industry’s hospitals and provider groups, has announced ... portal for select customers. Parasail Health is a San Francisco health-finance startup that ...
(Date:6/27/2017)... ... ... From June 20-22, EarQ and Widex held an exclusive training event ... is headquartered. , Together, the organizations educate hearing care professionals on how to ... latest in hearing technology. At the event, EarQ members got an in-depth look ...
(Date:6/27/2017)... ... June 27, 2017 , ... The Kelahan Agency, ... services to residents of southern New Hampshire, is teaming up with the New ... hunger and homelessness in the region. , New Horizons for New Hampshire provides ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... June 19, 2017  Researchers from DRUGSCAN ® ... will host a live, complimentary webinar titled, "Untangling methods ... to the real world" on Wednesday June 28, 2017 ... This webinar will feature interviews with recreational and ... the manipulation techniques abusers use to prepare opioid tablets ...
(Date:6/14/2017)... -- In 2016, Embodied Labs took top prize ... came away with $25,000 in seed-fund investment. Embodied Labs ... "entering the life of another" and by the Journal ... medical professionals in an entirely new dimension." Building upon ... for the Department of Education,s EdSimChallenge, where they received ...
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
Breaking Medicine Technology: